Lori Weisenfeld, DPM
Podiatrist · New York, NYNPI 1871517300
Payments from drug & device makers
Across 20 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$47
- AbbVie$45
- Journey Medical Corporation$38
- Merck$35
- Sebela Pharmaceuticals Inc.$31
- Abbott$31
- plus $184 from 8 others
What the payments were for
- Food & beverage$412100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 2 | $47 |
| AbbVie | 2 | $45 |
| Journey Medical Corporation | 3 | $38 |
| Merck | 2 | $35 |
| Sebela Pharmaceuticals Inc. | 2 | $31 |
| Abbott | 1 | $31 |
| Orthofix Medical, Inc. | 1 | $28 |
| Sun Pharmaceutical Industries Inc. | 1 | $28 |
| DJO, LLC | 1 | $25 |
| Medtronic | 1 | $22 |
| Bioventus LLC | 1 | $22 |
| Sandoz | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Melinta Therapeutics, LLC | 1 | $17 |
How this compares
$412 in reported general payments places this provider in the 45th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 65 | $1,316 |
| Fluconazole | 14 | $859 |
| Terbinafine Hcl | 36 | $413 |
| CiclopiroxCiclopirox Olamine | 13 | $256 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in New York
- Elvis DanneNew York$35K
- Siddhartha SharmaNew York$13K
- Neil ZwiebelNew York$12K
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Adam CirlincioneGlen Cove$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.